超越标记指数的Ki-67抗原在肿瘤内的分布用于临床决策：一种新的计数方法 - Suppr

Suppr

超能文献

Intratumor Distribution of Ki-67 Antigen Beyond Labeling Index for Clinical Decision-Making: A New Way of Counting.

作者信息

Bulloni Matteo, Pattini Linda, Pelosi Giuseppe

机构信息

Department of Electronics, Information, and Bioengineering, Politecnico di Milano, Milan, Italy.

Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

出版信息

JTO Clin Res Rep. 2021 Sep 24;2(9):100207. doi: 10.1016/j.jtocrr.2021.100207. eCollection 2021 Sep.

DOI:10.1016/j.jtocrr.2021.100207

PMID:34734194

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8486920/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3563/8486920/a96df7790574/gr1.jpg

相似文献

Intratumor Distribution of Ki-67 Antigen Beyond Labeling Index for Clinical Decision-Making: A New Way of Counting.

JTO Clin Res Rep. 2021 Sep 24;2(9):100207. doi: 10.1016/j.jtocrr.2021.100207. eCollection 2021 Sep.

In Response to "Intratumor Distribution of Ki-67 Antigen Beyond Labeling Index for Clinical Decision Making: A New Way of Counting".

JTO Clin Res Rep. 2021 Sep 24;2(9):100215. doi: 10.1016/j.jtocrr.2021.100215. eCollection 2021 Sep.

[Correlation of intratumor DNA ploidy distribution pattern and Ki-67 index in large bowel carcinomas].

Gan To Kagaku Ryoho. 1995 Jun;22 Suppl 2:181-5.

Comparison of visual assessment and image analysis in the evaluation of Ki-67 expression and their prognostic significance in immunohistochemically defined luminal breast carcinoma.

Jpn J Clin Oncol. 2016 Dec;46(12):1081-1087. doi: 10.1093/jjco/hyw107. Epub 2016 Aug 10.

The use of digital images improves reproducibility of the ki-67 labeling index as a proliferation marker in breast cancer.

Pathol Oncol Res. 2014 Apr;20(2):391-7. doi: 10.1007/s12253-013-9708-z. Epub 2013 Nov 8.

Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are applied.

Virchows Arch. 2017 Feb;470(2):153-164. doi: 10.1007/s00428-016-2062-2. Epub 2017 Jan 4.

Comparison of Ki-67 labeling index measurements using digital image analysis and scoring by pathologists.

Breast Cancer. 2018 Nov;25(6):768-777. doi: 10.1007/s12282-018-0885-1. Epub 2018 Jun 29.

Automated characterization and counting of Ki-67 protein for breast cancer prognosis: A quantitative immunohistochemistry approach.

Comput Methods Programs Biomed. 2017 Feb;139:149-161. doi: 10.1016/j.cmpb.2016.11.002. Epub 2016 Nov 9.

Interobserver reproducibility of MIB-1 labeling index in astrocytic tumors using different counting methods.

Mod Pathol. 2003 Sep;16(9):951-7. doi: 10.1097/01.MP.0000084631.64279.BC.

Prognostic significance of Ki-67 expression for patients with laryngeal squamous cell carcinoma primarily treated by total laryngectomy.

Eur Arch Otorhinolaryngol. 2004 Aug;261(7):376-80. doi: 10.1007/s00405-003-0699-3. Epub 2003 Nov 6.

引用本文的文献

In Response to "Intratumor Distribution of Ki-67 Antigen Beyond Labeling Index for Clinical Decision Making: A New Way of Counting".

JTO Clin Res Rep. 2021 Sep 24;2(9):100215. doi: 10.1016/j.jtocrr.2021.100215. eCollection 2021 Sep.

本文引用的文献

Ki67 (MIB-1) as a Prognostic Marker for Clinical Decision Making Before Extended Pleurectomy Decortication in Malignant Pleural Mesothelioma.

JTO Clin Res Rep. 2021 Feb 15;2(4):100155. doi: 10.1016/j.jtocrr.2021.100155. eCollection 2021 Apr.

Ki-67 Labeling Index in Pulmonary Carcinoid Tumors: Comparison Between Small Biopsy and Resection Using Tumor Tracing and Hot Spot Methods.

Arch Pathol Lab Med. 2020 Jan 16. doi: 10.5858/arpa.2019-0374-OA.

Ki-67 Evaluation for Clinical Decision in Metastatic Lung Carcinoids: A Proof of Concept.

Clin Pathol. 2019 Feb 19;12:2632010X19829259. doi: 10.1177/2632010X19829259. eCollection 2019 Jan-Dec.

Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices.

Mod Pathol. 2019 Jul;32(8):1106-1122. doi: 10.1038/s41379-019-0248-2. Epub 2019 Mar 28.

Recent advances in the molecular landscape of lung neuroendocrine tumors.

Expert Rev Mol Diagn. 2019 Apr;19(4):281-297. doi: 10.1080/14737159.2019.1595593. Epub 2019 Mar 27.

Pathologic Grading of Malignant Pleural Mesothelioma: An Evidence-Based Proposal.

J Thorac Oncol. 2018 Nov;13(11):1750-1761. doi: 10.1016/j.jtho.2018.07.002. Epub 2018 Jul 7.

The use of Ki-67 labeling index to grade pulmonary well-differentiated neuroendocrine neoplasms: current best evidence.

Mod Pathol. 2018 Oct;31(10):1523-1531. doi: 10.1038/s41379-018-0076-9. Epub 2018 May 25.

Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time.

Ann Oncol. 2018 May 1;29(5):1258-1265. doi: 10.1093/annonc/mdy086.

Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are applied.

Virchows Arch. 2017 Feb;470(2):153-164. doi: 10.1007/s00428-016-2062-2. Epub 2017 Jan 4.

Neuroendocrine Tumors of the Lung: Current Challenges and Advances in the Diagnosis and Management of Well-Differentiated Disease.

J Thorac Oncol. 2017 Mar;12(3):425-436. doi: 10.1016/j.jtho.2016.11.2222. Epub 2016 Nov 24.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验